P2X7-dependent release of interleukin-1beta and nociception in the spinal cord following lipopolysaccharide - Test2 - elhamkhani - TriplyDB

P2X7-dependent release of interleukin-1beta and nociception in the spinal cord following lipopolysaccharide

P2X7-dependent release of interleukin-1beta and nociception in the spinal cord following lipopolysaccharide

http://www.wikidata.org/entity/Q24600711

about

The role of purinergic receptors in cancer-induced bone pain The search for novel analgesics: targets and mechanisms Molecular and functional properties of P2X receptors--recent progress and persisting challenges Nociceptive transmission and modulation via P2X receptors in central pain syndrome Biological Roles of Resolvins and Related Substances in the Resolution of Pain From mechanosensitivity to inflammatory responses: new players in the pathology of glaucoma Microglia and spinal cord synaptic plasticity in persistent pain Neuronal and glial purinergic receptors functions in neuron development and brain disease P2X ion channel receptors and inflammation Emerging targets in neuroinflammation-driven chronic pain Emerging roles of resolvins in the resolution of inflammation and pain Activation of P2X7 receptor and NLRP3 inflammasome assembly in hippocampal glial cells mediates chronic stress-induced depressive-like behaviors Differential expression of P2X7 receptor and IL-1β in nociceptive and neuropathic pain.Long-term potentiation of glycinergic synapses triggered by interleukin 1β.Neuromodulation by extracellular ATP and P2X receptors in the CNS.Neuronal P2X7 receptor-induced reactive oxygen species production contributes to nociceptive behavior in mice Pathological pain and the neuroimmune interface.Inhibition of inflammatory mediator release from microglia can treat ischemic/hypoxic brain injury Dual induction of TREM2 and tolerance-related transcript, Tmem176b, in amyloid transgenic mice: implications for vaccine-based therapies for Alzheimer's disease.BDNF released during neuropathic pain potentiates NMDA receptors in primary afferent terminals Haplotypes of P2RX7 gene polymorphisms are associated with both cold pain sensitivity and analgesic effect of fentanyl.Tumor necrosis factor-α increases brain-derived neurotrophic factor expression in trigeminal ganglion neurons in an activity-dependent manner Interactions between the immune and nervous systems in pain.Toll-like receptor signaling in neural plasticity and disease.Activation of toll like receptor 4 attenuates GABA synthesis and postsynaptic GABA receptor activities in the spinal dorsal horn via releasing interleukin-1 beta.Neuronal soma-satellite glial cell interactions in sensory ganglia and the participation of purinergic receptors.Cell-autonomous regulation of hematopoietic stem cell cycling activity by ATP.Microglia: a promising target for treating neuropathic and postoperative pain, and morphine tolerance Inhibition of the P2X7 receptor reduces cystogenesis in PKD.Transcriptional control mechanisms associated with the nucleotide receptor P2X7, a critical regulator of immunologic, osteogenic, and neurologic functions.Peripheral indoleamine 2,3-dioxygenase 1 is required for comorbid depression-like behavior but does not contribute to neuropathic pain in mice.P2RX7 sensitizes Mac-1/ICAM-1-dependent leukocyte-endothelial adhesion and promotes neurovascular injury during septic encephalopathy Neuropathic Pain Phenotype Does Not Involve the NLRP3 Inflammasome and Its End Product Interleukin-1β in the Mice Spared Nerve Injury Model.Interleukin-1β in Central Nervous System Injury and Repair.Priming of adult pain responses by neonatal pain experience: maintenance by central neuroimmune activity.Toll-like receptors in chronic pain.Chronic ethanol exposure combined with high fat diet up-regulates P2X7 receptors that parallels neuroinflammation and neuronal loss in C57BL/6J mice.Emerging role of Toll-like receptors in the control of pain and itch.Genetically determined P2X7 receptor pore formation regulates variability in chronic pain sensitivity.Chronic inflammation and pain in a tumor necrosis factor receptor (TNFR) (p55/p75-/-) dual deficient murine model

P2860

Q21284976-195E47B8-7834-46BF-BBEA-AEBB102D12F1 Q24288817-42D2D700-13B6-431B-B166-C75DF59F9507 Q24617046-519F52C7-5EDC-4A10-8865-C6A9A5B8F741 Q26745701-E3A1B80B-6472-4108-BEDF-1ED88BFB5AE9 Q26784433-8A340911-63DF-457E-9ABA-722AC718A323 Q26864408-13EAF382-E360-43C4-BA41-55FECD0A97FE Q26866495-CF7E7958-4032-40CC-BCCB-89527B5C2D64 Q27500377-2C918AC8-799B-41E8-8A62-3BBAFC3AC113 Q28066934-90E060F9-E12A-404F-9369-C739907A29D8 Q28242435-E02B2B71-EB04-496D-8EA9-916F3A1ED354 Q28249435-E076FCC1-2FEE-40E9-8502-95820350366D Q29994732-C6C68B3F-C7DA-463B-A08F-F4EA7A7032DB Q30384063-3FBE8F8D-3675-4351-8698-6D7A181CD9AF Q33730485-4B5DBECA-4EC9-4325-9DDB-7ABBE323D79F Q33781729-81F44EC8-95EC-4CB1-9406-7CE5EF199C3E Q33799452-E508F8B2-B096-49E0-9457-2DFF14D3CC85 Q33925677-D35EF0AA-C3DD-4857-8038-320AE9C7BF30 Q33936874-3D1C3FA3-8C4C-4F6C-B83F-912EC6646E01 Q33999537-DAD21652-F116-404C-9779-92D6E3313880 Q34005579-7A823909-B7BF-432E-AB22-0C57A8DCD596 Q34695004-9CB47080-B1FF-41CE-825C-6FD5AE643D5F Q34762136-92BAA806-FA12-4484-A7EB-32EDA1A4F9AB Q34799654-0916404E-7601-45FD-B521-311ACBF19690 Q34984865-D2C39C05-6B80-4A5C-A9F1-A8F0431D25E6 Q34997571-B0DFC803-88C2-45A3-B7F2-98B118AFB910 Q35060291-26455F9D-13D3-4B3D-825F-7F48DDB3C7E4 Q35092822-D32E9AA2-46EE-45F8-99AF-4EECDD693488 Q35204830-7BCB88CF-113E-4AC7-AB97-3CE4092B15B0 Q35210209-0C4EE843-6BF0-462E-BCAB-61A927A9401C Q35468810-2CD9A396-15DF-49F4-86B3-88B679F5F824 Q35554122-AC50BC82-7272-4BA0-B1B7-C194AC34F5A5 Q35638779-A4722F81-5000-49B9-83D3-23700F8AC2CD Q35720256-0B34840A-3A1D-40C9-A494-704C7AD97F69 Q35737149-0B1203D8-2356-4B8A-BD7C-9957B9F9D165 Q35762455-0FDAA09B-56ED-4810-A3A4-60AEE952AF5F Q35830682-28838058-6DBE-4A71-A565-91D148CBC425 Q35882017-794D42D4-204C-44E4-A0F6-23D3D35C228D Q35944972-AA2B96F5-0C9E-4AFF-B47F-B00275F83B48 Q35953669-8A9DFF46-A97F-41CE-BA9D-50C855CB7196 Q36034905-9B575B5F-4019-4ACF-A641-E7EA5F50D37B

P2860

P2X7-dependent release of interleukin-1beta and nociception in the spinal cord following lipopolysaccharide

http://www.wikidata.org/entity/Q24600711

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

P2X7-dependent release of inte ...... d following lipopolysaccharide

@ast

P2X7-dependent release of inte ...... d following lipopolysaccharide

@en

P2X7-dependent release of inte ...... d following lipopolysaccharide

@nl

type

label

P2X7-dependent release of inte ...... d following lipopolysaccharide

@ast

P2X7-dependent release of inte ...... d following lipopolysaccharide

@en

P2X7-dependent release of inte ...... d following lipopolysaccharide

@nl

prefLabel

P2X7-dependent release of inte ...... d following lipopolysaccharide

@ast

P2X7-dependent release of inte ...... d following lipopolysaccharide

@en

P2X7-dependent release of inte ...... d following lipopolysaccharide

@nl

P1433

Q24600711-182F5F89-D4B1-466D-9943-25CEC518BB9C

P1476

Q24600711-9E5765F7-C125-4911-8C26-11F5CA5DCB38

P2093

Q24600711-35256B2E-F981-4CA8-B361-222BC586C886

Q24600711-AAABC42D-DF0C-48EF-98A1-392ED8D0F4F8

Q24600711-FD52D6AB-5B7A-48F8-8EF6-1BFD75C0448B

P2860

Q24600711-010FEB19-D16C-4C75-88E3-1017FE0826EB

Q24600711-05DD0047-A59B-4CCF-85B8-99B904EB88EA

Q24600711-075F010A-ABB8-4DD5-91E7-C2DF47DE3999

Q24600711-1074CCAF-F9F2-4739-B4CE-0D25E1175659

Q24600711-112402F3-1868-4F42-A23C-BFD2106CFE67

Q24600711-14CDCDA2-5560-4A2C-9BB0-4D59A92ACCB6

Q24600711-165C97AE-88EA-4B1D-8D77-68C67222C125

Q24600711-1A7AD0BD-0B53-487E-8DE0-8B36A48FD5D7

Q24600711-231AE78F-B3CA-4B0C-82E4-15CF4D5337C0

Q24600711-233A8419-FCCC-42C4-9D7F-EF2C68A95A9C

P304

Q24600711-A01497CB-1794-4B0D-8C72-130B11AFAF98

P31

Q24600711-0DD54C8F-00F6-42C2-84F8-3ED7B5D56FBB

P3181

Q24600711-C87D1AB2-75EA-4244-B6B7-871837B9135A

P356

Q24600711-1AC4875B-812A-44F4-A575-768CF7673028

P407

Q24600711-E72723F5-F328-4A03-9EEE-B330BAC7E5A9

P433

Q24600711-E54DE214-C154-4416-B23D-EE28093F5470

P478

Q24600711-BE1AEBB3-D19B-4559-A800-EE7067D45806

P50

Q24600711-11273EE6-651D-4DD7-A205-0208BE05462C

Q24600711-58A7AFF8-A303-4022-9371-63E522662FC3

Q24600711-DCE6D0C9-5567-4C9A-B4FA-BF8B28AE3870

P577

Q24600711-7593FAC7-A211-4817-B490-8E97C5BF0389

P698

Q24600711-F65DDC65-3498-43AE-B251-579B556D4F25

P921

Q24600711-199A3163-5521-4EBE-869B-4E0D12A55006

Q24600711-55c8b41c-7a0c-4cc8-b402-ae5cdd3bed21

P932

Q24600711-A96258B3-C41A-4ACD-8A7F-19134563776B

P3181

P356

JNEUROSCI.3295-09.2010

P1433

Journal of Neuroscience

P1476

P2X7-dependent release of inte ...... d following lipopolysaccharide

@en

P2093

Amelia A Staniland

http://www.w3.org/2001/XMLSchema#string

Fabien Marchand

http://www.w3.org/2001/XMLSchema#string

Timothy K Y Kaan

http://www.w3.org/2001/XMLSchema#string

P2860

The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta

Pannexin-1 mediates large pore formation and interleukin-1beta release by the ATP-gated P2X7 receptor

Pathological and protective roles of glia in chronic pain

P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury

Disruption of the P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain

Tissue distribution of the P2X7 receptor

Inflammatory caspases: linking an intracellular innate immune system to autoinflammatory diseases

A-740003 [N-(1-{[(cyanoimino)(5-quinolinylamino) methyl]amino}-2,2-dimethylpropyl)-2-(3,4-dimethoxyphenyl)acetamide], a novel and selective P2X7 receptor antagonist, dose-dependently reduces neuropathic pain in the rat

Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf

Cryopyrin activates the inflammasome in response to toxins and ATP

P304

573-82

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1252597

http://www.w3.org/2001/XMLSchema#string

P356

10.1523/JNEUROSCI.3295-09.2010

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

30

http://www.w3.org/2001/XMLSchema#string

P50

Marzia Malcangio

Stephen B McMahon

P577

2010-01-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20071520

http://www.w3.org/2001/XMLSchema#string

P921

lipopolysaccharide

P932

2880485

http://www.w3.org/2001/XMLSchema#string